Editorial: The Biological and Clinical Aspects of HLA-G, Volume II

Editorial: The Biological and Clinical Aspects of HLA-G, Volume II

Bibliographic Details
Main Authors:	Joel LeMaoult, Wei-Hua Yan
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-06-01
Series:	Frontiers in Immunology
Subjects:	HLA-G receptor immune regulation cancer autoimmune infection
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.959706/full

Similar Items

Editorial: The Biological and Clinical Aspects of HLA-G
by: Joel LeMaoult, et al.
Published: (2021-02-01)

Soluble HLA-G and HLA-G Bearing Extracellular Vesicles Affect ILT-2 Positive and ILT-2 Negative CD8 T Cells Complementary
by: Esther Schwich, et al.
Published: (2020-08-01)

Skin Immunity and Tolerance: Focus on Epidermal Keratinocytes Expressing HLA-G
by: Guillaume Mestrallet, et al.
Published: (2021-12-01)

Inhibition of iNKT Cells by the HLA-G-ILT2 Checkpoint and Poor Stimulation by HLA-G-Expressing Tolerogenic DC
by: Ching-Lien Wu, et al.
Published: (2021-01-01)

The role of methylation, DNA polymorphisms and microRNAs on HLA-G expression in human embryonic stem cells
by: A. Verloes, et al.
Published: (2017-03-01)

Intratumor heterogeneity of immune checkpoints in primary renal cell cancer: Focus on HLA-G/ILT2/ILT4
by: Nathalie Rouas-Freiss, et al.
Published: (2017-09-01)

The Dual Role of HLA-G in Cancer
by: Nathalie Rouas-Freiss, et al.
Published: (2014-01-01)

Human Keratinocytes Inhibit CD4<sup>+</sup> T-Cell Proliferation through TGFB1 Secretion and Surface Expression of HLA-G1 and PD-L1 Immune Checkpoints
by: Guillaume Mestrallet, et al.
Published: (2021-06-01)

Immunosuppressive Properties of Epidermal Keratinocytes Differ According to Their Immaturity Status
by: Guillaume Mestrallet, et al.
Published: (2022-02-01)

HLA-G molecules in autoimmune diseases and infections
by: Roberta eRizzo, et al.
Published: (2014-11-01)

Interactions between HLA-G and HLA-E in physiological and pathological conditions
by: Fabio eMorandi, et al.
Published: (2014-08-01)

HLA-G expression levels influence the tolerogenic activity of human DC-10
by: Giada Amodio, et al.
Published: (2015-04-01)

Perspective of HLA-G Induced Immunosuppression in SARS-CoV-2 Infection
by: Aifen Lin, et al.
Published: (2021-12-01)

Intercellular transfer of HLA‐G: its potential in cancer immunology
by: Aifen Lin, et al.
Published: (2019-01-01)

Diversity in the HLA-I Recognition of HLA-F Monoclonal Antibodies: HLA-F or HLA-Ib Monospecific, HLA-E or HLA-G Bispecific Antibodies with or without HLA-Ia Reactivity
by: Mepur H. Ravindranath, et al.
Published: (2024-01-01)

Associations of HLA-G 3’UTR polymorphisms and increased HLA-G expression with gastric cancer susceptibility and prognosis
by: Ines Zemni, et al.
Published: (2025-01-01)

HLA-G: Too Much or Too Little? Role in Cancer and Autoimmune Disease
by: José Manuel Martín-Villa, et al.
Published: (2022-01-01)

Tolerogenic function of dimeric forms of HLA-G recombinant proteins: a comparative study in vivo.
by: Benoit Favier, et al.
Published: (2011-01-01)

HLA-G 3’UTR polymorphism diplotypes and soluble HLA-G plasma levels impact cervical cancer susceptibility and prognosis
by: Jun Gan, et al.
Published: (2022-12-01)

The Effects of HLA-G Gene Polymorphism and sHLA-G Level in Women with Threatened Abortion
by: Ahmed H. Merdas, et al.
Published: (2022-06-01)

HLA Class I or Class II and Disease Association: Catch the Difference If You Can
by: Maria Teresa Fiorillo, et al.
Published: (2017-11-01)

HLA-G5 and G7 Isoforms in Pregnant Women
by: Saeid Abediankenari, et al.
Published: (2015-04-01)

HLA-G in Allergy: Does It Play an Immunoregulatory Role?
by: Simone Negrini, et al.
Published: (2022-01-01)

Meta-analysis of HLA-G 14bp insertion/deletion polymorphism and soluble HLA-G revealed an association with digestive cancers initiation and prognosis
by: Sabrine Dhouioui, et al.
Published: (2022-07-01)

HLA-G/ILTs Targeted Solid Cancer Immunotherapy: Opportunities and Challenges
by: Aifen Lin, et al.
Published: (2021-06-01)

Structural Modeling and Molecular Dynamics of the Immune Checkpoint Molecule HLA-G
by: Thais Arns, et al.
Published: (2020-11-01)

Biological Characteristics of HLA-G and Its Role in Solid Organ Transplantation
by: Siqi Liu, et al.
Published: (2022-06-01)

Intratumor Heterogeneity of HLA-G Expression in Cancer Lesions
by: Xia Zhang, et al.
Published: (2020-11-01)

Recombinant HLA-G as Tolerogenic Immunomodulant in Experimental Small Bowel Transplantation.
by: Martin W von Websky, et al.
Published: (2016-01-01)

First immunotherapeutic CAR-T cells against the immune checkpoint protein HLA-G
by: Olivier Adotevi, et al.
Published: (2021-03-01)

HLA-G/sHLA-G and HLA-G-Bearing Extracellular Vesicles in Cancers: Potential Role as Biomarkers
by: Peilong Li, et al.
Published: (2021-11-01)

Impact of HLA-G in the outcome of vitiligo in Tunisian patients
by: Jalel Akrem, et al.
Published: (2010-01-01)

HLA DRB1* ASSOCIATION WITH REPRODUCTIVE DISORDERS IN WOMEN
by: L. A. Gordeeva, et al.
Published: (2014-07-01)

Expression of the Non-classical HLA-E, -F, -G Molecules in the Tumour Microenvironment
by: Ormandjieva Anastasia
Published: (2023-08-01)

Comprehensive Transcriptomic Analysis Reveals the Role of the Immune Checkpoint HLA-G Molecule in Cancers
by: Hui-Hui Xu, et al.
Published: (2021-07-01)

Harnessing the potential of HLA-G in cancer therapy: advances, challenges, and prospects
by: Siyuan Wang, et al.
Published: (2024-02-01)

HLA-G: An Important Mediator of Maternal-Fetal Immune-Tolerance
by: Baimei Zhuang, et al.
Published: (2021-10-01)

HLA-G Expression in Lung Adenocarcinoma Tissues and Its Relationship with Prognosis
by: ZHANG Wenlong, et al.
Published: (2018-08-01)

HLA-G Expression Pattern: Reliable Assessment for Pregnancy Outcome Prediction
by: Elnaz Mosaferi, et al.
Published: (2013-08-01)

Controlling the immunological crosstalk during conception and pregnancy: HLA-G in reproduction
by: Line eLynge Nilsson, et al.
Published: (2014-05-01)